Adimmune Balance Sheet Health
Financial Health criteria checks 6/6
Adimmune has a total shareholder equity of NT$5.6B and total debt of NT$2.6B, which brings its debt-to-equity ratio to 45.3%. Its total assets and total liabilities are NT$8.6B and NT$3.0B respectively.
Key information
45.3%
Debt to equity ratio
NT$2.55b
Debt
| Interest coverage ratio | n/a |
| Cash | NT$1.86b |
| Equity | NT$5.64b |
| Total liabilities | NT$2.98b |
| Total assets | NT$8.62b |
Recent financial health updates
Recent updates
Little Excitement Around Adimmune Corporation's (TWSE:4142) Revenues
Aug 13
Shareholders Can Be Confident That Adimmune's (TPE:4142) Earnings Are High Quality
Apr 05Is Adimmune (TPE:4142) Using Debt In A Risky Way?
Mar 01Introducing Adimmune (TPE:4142), The Stock That Zoomed 158% In The Last Three Years
Jan 07Financial Position Analysis
Short Term Liabilities: 4142's short term assets (NT$3.7B) exceed its short term liabilities (NT$1.1B).
Long Term Liabilities: 4142's short term assets (NT$3.7B) exceed its long term liabilities (NT$1.8B).
Debt to Equity History and Analysis
Debt Level: 4142's net debt to equity ratio (12.2%) is considered satisfactory.
Reducing Debt: 4142's debt to equity ratio has reduced from 68.5% to 45.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4142 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 4142 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 15.2% each year